From: Modelling attrition and nonparticipation in a longitudinal study of prostate cancer
 |  | Deceased or Frailb, c | Lost to Follow-Upb, d | Refusale | |||
---|---|---|---|---|---|---|---|
 |  | AAa | EAa | AA | EA | AA | EA |
Age at Diagnosis | 70–79 | 2.03 (0.89–4.61) | 2.30 (0.98–5.44) | 0.36 (0.14–0.93) | 0.27 (0.06–1.23) | 1.03 (0.5–2.11) | 1.38 (0.73–2.60) |
60–69 | 0.81 (0.37–1.73) | 1.06 (0.45–2.48) | 0.37 (0.18–0.73) | 0.47 (0.15–1.53) | 0.99 (0.57–1.73) | 0.84 (0.46–1.53) | |
Study Phase | Post-Ka | 0.41 (0.20–0.88) | 0.46 (0.22–0.94) | 1.12 (0.48–2.62) | 0.96 (0.25–3.72) | 0.76 (0.40–1.45) | 0.73 (0.38–1.40) |
Income | $0–30,000 | 13.42 (0.84–214.98) | 1.49 (0.58–3.78) | 2.48 (0.86–7.13) | 8.65 (1.88–39.77) | 1.01 (0.44–2.30) | 2.79 (1.34–5.81) |
$30,001–70,000 | 14.13 (0.88–225.87) | 1.21 (0.56–2.63) | 1.48 (0.49–4.45) | 1.99 (0.44–9.05) | 1.34 (0.61–2.95) | 1.96 (1.07–3.58) | |
Education | ≤ High School | 1.37 (0.63–2.99) | 1.15 (0.55–2.42) | 1.92 (0.90–4.09) | 2.18 (0.68–7.05) | 1.34 (0.75–2.41) | 1.29 (0.73–2.30) |
REALMa Score | ≤ 6th | 1.36 (0.58–3.21) | 0.95 (0.26–3.44) | 1.18 (0.51–2.74) | 0.46 (0.07–2.91) | 0.94 (0.47–1.86) | 0.81 (0.33–2.00) |
7th - 8th | 0.47 (0.18–1.20) | 2.20 (0.98–4.92) | 0.74 (0.30–1.80) | 1.25 (0.35–4.52) | 0.62 (0.31–1.21) | 0.64 (0.30–1.39) | |
Cancer Aggressiveness | Intermediate | 1.12 (0.55–2.30) | 1.16 (0.55–2.45) | 1.01 (0.49–2.06) | 0.66 (0.20–2.23) | 1.03 (0.59–1.80) | 0.57 (0.32–1.01) |
High | 2.98 (1.34–6.62) | 4.09 (1.94–8.63) | 2.17 (0.99–4.76) | 1.17 (0.28–4.90) | 2.51 (1.34–4.72) | 1.07 (0.54–2.10) | |
PPCa Score |  | 0.77 (0.54–1.09) | 0.91 (0.60–1.38) | 1.23 (0.83–1.81) | 1.05 (0.53–2.10) | 0.76 (0.58–1.01) | 0.70 (0.51–0.96) |
CCIa |  | 1.26 (1.03–1.54) | 1.17 (0.98–1.39) | 0.86 (0.65–1.12) | 0.91 (0.61–1.37) | 1.00 (0.83–1.21) | 0.96 (0.80–1.15) |